NCT07001748 2026-03-23
STOPGAP II
Eastern Cooperative Oncology Group
Phase 2/3 Recruiting
Clinical Trials
4 trialsNCT04093167 2026-03-11
Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer
Canadian Cancer Trials Group
Phase 2/3 Recruiting
NCT06616584 2026-01-23
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
SWOG Cancer Research Network
Phase 2/3 Recruiting
NCT03851445 2025-12-05
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
SWOG Cancer Research Network
Phase 2/3 Recruiting